Charles Schwab
OCGN icon

Charles Schwab’s Ocugen OCGN Stock Holding History

Charles Schwab’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
1,042,537
+830,443
+392% +$1.26M ﹤0.01% 2861
2026
Q1 		$384K Buy
212,094
+40,371
+24% +$69.8K ﹤0.01% 3188
2025
Q4 		$232K Hold
171,723
– – ﹤0.01% 3327
2025
Q3 		$280K Hold
171,723
– – ﹤0.01% 3306
2025
Q2 		$167K Sell
171,723
-688,521
-80% -$571K ﹤0.01% 3391
2025
Q1 		$608K Hold
860,244
– – ﹤0.01% 3011
2024
Q4 		$692K Buy
860,244
+93,288
+12% +$85.4K ﹤0.01% 3040
2024
Q3 		$761K Sell
766,956
-9,060
-1% -$12.4K ﹤0.01% 3004
2024
Q2 		$1.2M Buy
776,016
+605,762
+356% +$944K ﹤0.01% 2854
2024
Q1 		$279K Hold
170,254
– – ﹤0.01% 3191
2023
Q4 		$97.9K Hold
170,254
– – ﹤0.01% 3350
2023
Q3 		$68.1K Sell
170,254
-963,766
-85% -$476K ﹤0.01% 3381
2023
Q2 		$616K Sell
1,134,020
-384,808
-25% -$247K ﹤0.01% 2954
2023
Q1 		$1.3M Sell
1,518,828
-101,478
-6% -$111K ﹤0.01% 2652
2022
Q4 		$2.11M Buy
1,620,306
+61,826
+4% +$96.4K ﹤0.01% 2558
2022
Q3 		$2.77M Buy
1,558,480
+35,845
+2% +$89.2K ﹤0.01% 2482
2022
Q2 		$3.46M Buy
1,522,635
+111,734
+8% +$267K ﹤0.01% 2353
2022
Q1 		$4.66M Buy
1,410,901
+39,674
+3% +$139K ﹤0.01% 2314
2021
Q4 		$6.24M Buy
1,371,227
+20,107
+1% +$152K ﹤0.01% 2240
2021
Q3 		$9.7M Buy
1,351,120
+883,662
+189% +$6.49M ﹤0.01% 2028
2021
Q2 		$3.75M Buy
467,458
+399,181
+585% +$3.37M ﹤0.01% 2484
2021
Q1 		$464K Buy
+68,277
New +$454K ﹤0.01% 3105

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Charles Schwab's OCGN Position: Q2 2026 in Review

Charles Schwab increased its Ocugen (OCGN) stake by 392% in Q2 2026, buying an estimated $1.26M and bringing the position to 1,042,537 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2861.

Charles Schwab first reported a position in OCGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $9.7M in Q3 2021. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Charles Schwab held 1,042,537 shares of Ocugen worth $1.6M as of Q2 2026.
  • Charles Schwab bought 830,443 Ocugen shares in Q2 2026, an estimated $1.26M.
  • Ocugen made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2861 holding.
  • Charles Schwab first reported a position in Ocugen in Q1 2021 and has held it in 22 quarters since.
  • Charles Schwab's Ocugen position peaked at $9.7M in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.